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Introduction: Linezolid-induced black hairy tongue has been rarely reported. The purpose of this paper is to report
a case of linezolid-induced black hairy tongue and review the literature.
Case presentation: A 56-year-old Caucasian man was admitted with community-acquired pneumonia that failed
to respond to levofloxacin 750mg daily. He was started on linezolid and meropenem and was subsequently
discharged home on oral linezolid 600mg every 12 hours and intravenous ertapenem 1g daily. On a follow-up
clinic visit, day 14 of linezolid therapy, he complained of dysgeusia and his tongue examination was consistent with
black hairy tongue. After he finished his antibiotic course, his complaints resolved with regular tongue brushing.
Conclusion: Black hairy tongue is characterized by abnormal hypertrophy and elongation of filiform papillae. Five
reported cases of linezolid-induced black hairy tongue were identified in a MEDLINE search (from January 2000 to
June 2012). The Naranjo Probability Scale revealed a probable adverse drug reaction of linezolid-induced black hairy
tongue. Potential contributing factors included other antibiotics, drug–drug interaction and poor oral hygiene.
Health care professionals should be aware of the possibility of linezolid-induced black hairy tongue. Thorough
history for other possible contributing factors should be obtained. Patients on linezolid should be counseled to
perform good oral hygiene.
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Linezolid is an oxazolidinone antimicrobial drug active
against antibiotic-resistant Gram-positive bacteria inclu-
ding methicillin-resistant Staphylococcus aureus (MRSA)
and vancomycin-resistant enterococci [1]. Its high oral
bioavailability provides a definite economic advantage
compared with other MRSA therapeutic options, allowing
earlier hospital discharge and reducing out-patient therapy
cost. Linezolid is well-tolerated with nausea, vomiting,
diarrhea and headache being the most commonly repor
ted side effects [2]. Bone marrow suppression and
neuropathies may occur in patients taking this antibiotic
for more than two weeks.
Black hairy tongue (BHT) is a benign disorder
characterized by hypertrophy and discoloration of the fili-
form papillae of the tongue [3]. This disorder has been
associated with numerous medications and predisposing* Correspondence: faisal.khasawneh@ttuhsc.edu
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distribution, and reproduction in any mediumconditions. Linezolid-induced BHT has rarely been
reported. This report examines a case of BHT believed to
be caused by linezolid.
Case presentation
A 56-year-old Caucasian man was admitted with acute-
onset right-sided chest pain, shortness of breath, dry
cough and fever. Chest X-ray findings were consistent
with a right lower lobe pneumonia. Pulmonary computed
tomography (CT) angiogram was negative for pulmonary
embolism. After a three-day hospitalization, during which
he received intravenous levofloxacin 750mg daily, he was
discharged home on oral levofloxacin at 750mg daily. The
patient was re-admitted four days later with worsening
symptoms despite reporting compliance with antibiotic
therapy. Follow-up chest imaging showed worsening right
lower lobe infiltrate with new effusion. Failure to respond
to levofloxacin raised concerns of multidrug-resistant
bacteria. The patient was started on linezolid 600mg every
12 hours and meropenem one g every eight hours.
He underwent a right-sided pleurocentesis to drain antral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cultures were negative. The result of a human immuno-
deficiency virus serology test was negative. Urine legionella
and histoplasma antigens were negative. After a six-day
hospitalization, the patient’s condition improved and he
was discharged home on intravenous ertapenem one g
daily and oral linezolid 600mg every 12 hours to finish a
10-day course.
Eight days after discharge, the patient presented to the
infectious disease clinic for follow up. He reported sig-
nificant improvement in his respiratory symptoms and
denied fever. He reported blackish discoloration of his
tongue and dysgeusia. The patient was edentulous and
denied brushing or regular mouthwash use. He denied
drinking tea or the excessive consumption of coffee or
other colored beverages. The patient was a cigarette
smoker but had quit since his initial hospitalization
21 days prior. Aside from the above antibiotics, he was
also taking hydrocodone and acetaminophen, five mg
and 500mg, respectively, every six hours and albuterol
and ipratropium bromide metered-dose inhaler every six
hours.
On examination, the patient was afebrile with normal
heart rate and blood pressure. There was a brownish-
black discoloration of his tongue that spared the tip and
the sides (Figure 1). The discoloration could not beFigure 1 Brownish-black discoloration of the posterior
two-thirds of the tongue after two weeks of linezolid therapy.wiped by gauze. There was no discoloration of the
buccal mucosa. There were no palpable cervical lymph
nodes. He had no skin rash and his lung examination
demonstrated significant improvement in air entry to
the right lower lobe with minimal crackles.
No blood tests were done. A swab for fungal and bac-
terial cultures grew normal oral flora. A liquid-based cy-
tology preparation (ThinPrep smear) of the tongue
showed food fibers but no yeast cells. The patient was
diagnosed with BHT. He was reassured and was asked
to finish his antibiotic course. He was directed to clean
his tongue with a soft toothbrush and baking soda-
containing toothpaste twice daily. A follow up visit four
weeks later showed complete resolution of tongue dis-
coloration (Figure 2).
Discussion
Using the Naranjo Adverse Drug Reaction Probability
Scale we present a case of probable linezolid-induced
BHT in a 56-year-old man [4]. The patient’s concomi-
tant medications have not been reported to cause BHT.
Although a drug–drug interaction is a remote possibility,
to the best of our knowledge, no such interactions have
been reported. The occurrence of linezolid-induced
BHT in our patient was probably aggravated by his poor
oral hygiene. Other known causes were ruled out, in-
cluding cigarette smoking because the patient had quit
approximately three weeks prior to presentation.
Linezolid-induced BHT has been previously reported
[5-9]. A MEDLINE search (from January 2000 to June
2012) revealed five reported cases. The median duration
from initiating linezolid to the diagnosis of discoloration
in the reported cases was two weeks (range: from two
days to two weeks). The discoloration resolved after
stopping linezolid in all reported cases after a median of
seven days (range: from three days to six months). In
two of the reported cases, the authors did not observe
changes in the filiform papillae, labeling their patients
with linezolid-induced tongue discoloration rather than
BHT [5,6]. The possibility of early BHT, which might
have been difficult to diagnose on clinical examination,
was not entertained. The details of reported cases, in-
cluding the current case, are presented in Table 1.
The safety profile of linezolid has been well documented.
In a study comparing linezolid and dicloxacillin for skin
and soft tissue infections, the most frequently reported ad-
verse events in the linezolid group were nausea (5.8%),
headache (5.5%) and vomiting (3.3%) [2]. Longer courses
of linezolid, more than two to four weeks, have been
associated with reversible myelosuppression and neur-
opathy. In comparator-controlled trials for the treatment
of skin and soft tissue infections, tongue discoloration
associated with linezolid administration was reported in
1.1% of patients [9].
Figure 2 Complete resolution of the patient’s black hairy tongue four weeks after discontinuation of linezolid.
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mal hypertrophy and elongation of filiform papillae on
the surface of the tongue [3]. There are no objective cri-
teria for diagnosing this condition [10]. Although BHT
is usually asymptomatic, occasionally patients may com-
plain of tickling or burning of the tongue, nausea, hali-
tosis, dysgeusia and unattractive appearance of the tongue
[3]. The color black has been used to characterize this
condition historically; however, brown, yellow and green
discolorations have also been reported [3]. BHT is caused
by defective desquamation of the dorsal surface of the
tongue, usually in the posterior one-third [10]. This
defective desquamation prevents normal debridement
resulting in excessive growth and thickening of the filiformTable 1 Reported cases of linezolid-induced tongue discolora
Patient gender, age
(years)
Clinical indication for linezolid
therapy
Con
Male, 65* Ampicillin-resistant enterococcal




Male, 74 Staphylococcal skin infection
in a lymphoma patient
NR
Female, 8** MRSA septic arthritis NR
Male, 42* Empiric therapy for diskitis
following laminectomy
Rifam
Female, 40 Disseminated nocardial
infection in a patient with SLE
Ster
SMX





Abbreviations: MDI: metered-dose inhaler, MRSA: methicillin-resistant Staphylococcu
erythematosus, TMP and SMX: trimethoprim and sulfamethoxazole, UTI: urinary trac
*The authors did not observe filiform papillae changes on clinical examination and labele
**The authors described tongue discoloration but did not comment on the possibilpapillae that then collect debris, bacteria, fungi or other
foreign materials which contribute to the discoloration.
The exact mechanism of drug-induced BHT is unknown.
Several factors have been implicated in causing and/or
aggravating BHT; these include smoking or chewing
tobacco, drinking alcohol, poor oral hygiene, smoking
crack cocaine or other street drugs, using peroxide-
containing mouthwash, radiation therapy, trigemi-
nal neuralgia, using drugs that cause xerostomia like
anticholinergics, antihypertensives and antidepressants,
and antibiotics such as tetracyclines and penicillins [11].
The diagnosis of BHT relies on the visual identification
of discolored, elongated, and hypertrophied filiform papil-
lae. Taking a detailed history is important in identifyingtion and black hairy tongue
















s aureus, NR: not reported, Ref #: reference number, SLE: systemic lupus
t infection.
d their patients with linezolid-induced tongue discoloration not black hairy tongue.
ity of black hairy tongue.
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ation of the offending agent alongside practicing good oral
hygiene usually resolves the problem [11]. Gentle tongue
debridement can be accomplished by cleaning the tongue
with a soft toothbrush and a solution of 3% hydrogen per-
oxide or baking soda [3].
Conclusion
Linezolid-induced BHT is an uncommon, benign, self-
limiting disorder. Other antibiotics, drugs that cause
xerostomia, poor oral hygiene, smoking, and consump-
tion of coffee or other colored beverages are known or
probable risk factors. A thorough history should be
obtained to rule out these risk factors in the setting of
concomitant linezolid use. The prospective counseling of
patients on the importance of good oral hygiene when
taking this medication may be warranted. Further stu-
dies are needed to identify the exact mechanism of
linezolid-induced BHT and to develop objective criteria
for establishing the diagnosis.
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